Retraction notice to “Use of albumin: an update” [Br J Anaesth 104 (2010) 276–84] (British Journal of Anaesthesia (2020) 104(276–84), (10.1093/bja/aep393));Use of albumin: An update

British Journal of Anaesthesia

Volumn 104, Issue 3, 2010, Pages 276-284

  Boldt, J ^a  

^a KLINIKUM LUDWIGSHAFEN   (Germany)

Author keywords

Blood; Coagulation; Loss; Plasma; Protein; Surgery

Indexed keywords

HUMAN ALBUMIN; OXYGEN RADICAL;

BINDING AFFINITY; BURN PATIENT; DRUG TRANSPORT; FIRST TRIMESTER PREGNANCY; HUMAN; HYPOALBUMINEMIA; HYPOVOLEMIA; INTENSIVE CARE UNIT; LIVER CIRRHOSIS; LIVER SURGERY; MALABSORPTION; MALNUTRITION; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; REVIEW; TRAUMATIC BRAIN INJURY; TREATMENT INDICATION;

EID: 77249137816     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1016/j.bja.2020.07.039     Document Type: Erratum

References (76)

1. Alderson P, Bunn F, Li Wan Po A, et al. Human albumin solution for resuscitation and volume expansion in critically ill patients. Cochrane Database Syst Rev 2004; 18: CD001208
2. Altman C, Bernard B, Roulot D, Vitte RL, Ink O. Randomized comparative multicenter study of hydroxyethyl starch versus albumin as a plasma expander in cirrhotic patients with tense ascites treated with paracentesis. Eur J Gastroenterol Hepatol 1998; 10: 5-10
3. Angeli P, Volpin R, Gerunda G, et al. Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide. Hepatology 1999; 29: 1690-1697
4. Avorn J, Patel M, Levin R, Winkelmayer WC. Hetastarch and bleeding complications after coronary artery surgery. Chest 2003; 124: 1437-1442
5. Boldt J, Brosch Ch, Röhm K, Lehmann A, Mengistu A, Suttner S. Is albumin administration in hypoalbuminemic elderly cardiac surgery patients of benefit with regard to inflammation, endothelial activation, and long-term kidney function? Anesth Analg 2008; 107: 1496-1503
6. Boldt J, Pabsdorf M. Fluid management in burn patients: results from a European survey-more questions than answers. Burns 2008; 34: 328-338
7. Boldt J, Schö llhorn T, Mayer J, Piper S, Suttner S. The value of an albumin-based intravascular volume replacement strategy in elderly patients undergoing major abdominal surgery. Anesth Analg 2006; 103: 191-199
8. Cammu G, Troisi R, Cuomo O, de Hemptinne B, Di Florio E, Mortier E. Anaesthetic management and outcome in right-lobe living liver-donor surgery. Eur J Anaesthesiol 2002; 19: 93-98
9. Canver CC, Nichols RD. Use of intraoperative hetastarch priming during coronary bypass. Chest 2000; 118: 1616-1620
10. Charles A, Purtill M, Dickinson S, et al. Albumin use guidelines and outcome in a surgical intensive care unit. Arch Surg 2008; 143: 935-939
11. Chien S, Sinclair DG, Dellenback RJ, et al. Effect of endotoxin on capillary permeability to macromolecules. Am J Physiol 1964; 207: 518-522
12. Chong Sung K, Kum Suk P, Mi Ja Y, Kyoung Ok K. Effects of intravascular volume therapy using hydroxyethyl starch (130/0.4) on post-operative bleeding and transfusion requirements in children undergoing cardiac surgery: a randomized clinical trial. Acta Anaesthesiol Scand 2006; 50: 108-111
13. Cooper AB, Cohn SM, Zhang HS, Hanna K, Stewart TE, Slutsky AS, ALBUR Investigators. Five percent albumin for adult burn shock resuscitation: lack of effect on daily multiple organ dysfunction score. Transfusion 2006; 46: 80-89
14. Cope JT, Banks D, Mauney MC, et al. Intraoperative hetastarch infusion impairs hemostasis after cardiac surgery operations. Ann Thorac Surg 1997; 63: 78-82
15. Dellinger RP, Levy MM, Carlet JM, et al. International Surviving Sepsis Campaign. International guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008; 36: 296-327
16. Dubois MJ, Orellana-Jimenez C, Melot C, et al. Albumin administration improves organ function in critically ill hypoalbuminemic patients: a prospective, randomized, controlled, pilot study. Crit Care Med 2006; 34: 2536-2540
17. Duvoux C, Zanditenas D, Hezode C, Chauvat A, Metreau J. Effects of noradrenalin and albumin in patients with type 1 hepatorenal syndrome: a pilot study. Hepatology 2002; 36: 374-380
18. Evans TW. Review article: albumin as a drug-biological effects of albumin unrelated to oncotic pressure. Aliment Pharmacol Ther 2002; 16: 6-11
19. Fan C, Phillips K, Sellin S. Serum albumin: new thoughts on an old treatment. BC Med J 2005; 47: 438-444
20. Fassio E, Terg R, Landeira G, et al. Paracentesis with dextran 70 vs. paracentesis with albumin in cirrhosis with tense ascites. Results of a randomized study. J Hepatol 1992; 14: 310-316
21. Fernandez J, Monteagudo J, Bargallo X, et al. A randomized unblinded pilot study comparing albumin versus hydroxyethyl starch in spontaneous bacterial peritonitis. Hepatology 2005; 42: 627-634
22. Finfer S, Bellomo R, Boyce N, SAFE Study Investigators. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 2004; 350: 2247-2256 (Pubitemid 38669207)
23. Fleck A, Raines G, Hawker F, et al. Increased vascular permeability. Major cause of hypoalbuminaemia in disease and injury. Lancet 1985; 6: 781-784
24. Friedman G, Jankowski S, Shahla M, Gomez J, Vincent JL. Hemodynamic effects of 6% and 10% hydroxyethyl starch solutions versus 4% albumin solution in septic patients. J Clin Anesth 2008; 20: 528-533
25. Garcia-Compean D, Blanc P, Larrey D, et al. Treatment of cirrhotic tense ascites with Dextran-40 versus albumin associated with large volume paracentesis: a randomized controlled trial. Ann Hepatol 2002; 1: 29-35
26. Gentilini P, Casini-Raggi V, Di Fiore G, et al. Albumin improves the response to diuretics in patients with cirrhosis and ascites: results of a randomized, controlled trial. J Hepatol 1999; 30: 639-645
27. Gines A, Fernandez-Esparrach G, Monescillo A, et al. Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis. Gastroenterology 1996; 111: 1002-1010
28. Gines P, Tito L, Arroyo V, et al. Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis. Gastroenterology 1988; 94: 1493-1502
29. Green RS, Hall RI. Con: starches are not preferable to albumin during cardiac surgery: a contrary opinion. J Cardiothorac Vasc Anesth 2008; 22: 485-491
30. Greenhalgh DG, Housinger TA, Kagan RJ, et al. Maintenance of serum albumin levels in pediatric burn patients: a prospective, randomized trial. J Trauma 1995; 39: 67-73
31. Guthrie RD, Jr, Hines C, Jr. Use of intravenous albumin in the critically ill patient. Am J Gastroenterol 1991; 86: 255-263
32. Jacob M, Chappell D, Conzen P, Wilkes MM, Becker BF, Rehm M. Small-volume resuscitation with hyperoncotic albumin: a systematic review of randomized clinical trials. Crit Care 2008; 12: R34
33. Jardine LA, Jenkins-Manning S, Davies MW. Albumin infusion for low serum albumin in preterm newborn infants. Cochrane Database Syst Rev 2004; 3: CD004208
34. Knutson JE, Deering JA, Hall FW, et al. Does intraoperative hetastarch administration increase blood loss and transfusion requirements after cardiac surgery? Anesth Analg 2000; 90: 801-807
35. Margarson MP, Soni N. Serum albumin: touchstone or totem? Anaesthesia 1998; 53: 789-803
36. Martin GS, Moss M, Wheeler AP, Mealer M, Morris JA, Bernard GR. A randomized, controlled trial of furosemide with or without albumin in hypoproteinemic patients with acute lung injury. Crit Care Med 2005; 33: 1681-1687
37. Mendez CM, McClain CJ, Marsano LS. Albumin therapy in clinical practice. Nutr Clin Pract 2005; 20: 314-320
38. Moore KP, Aithal GP. Guidelines on the management of ascites in cirrhosis. Gut 2006; 55: 1-12
39. Moore KP, Wong F, Gines P, et al. The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club. Hepatology 2003; 38: 258-266
40. Moreau R, Durand F, Poynard T, et al. Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: a retrospective multicenter study. Gastroenterology 2002; 122: 923-930 (Pubitemid 34267275)
41. Moreau R, Valla DC, Durand-Zaleski I, et al. Comparison of outcome in patients with cirrhosis and ascites following treatment with albumin or a synthetic colloid: a randomised controlled pilot trial. Liver Int 2006; 26: 46-54
42. Mukhtar A, El Masry A, Moniem AA, Metini M, Fayez A, Khater YH. The impact of maintaining normal serum albumin level following living related liver transplantation: does serum albumin level affect the course? A pilot study. Transplant Proc 2007; 39: 3214-3218
43. Myburgh JA, Finfer S. Albumin is a blood product too-is it safe for all patients? Crit Care Resusc 2009; 11: 67-70
44. Nicholson JP, Wolmarans MR, Park GR. The role of albumin in critical illness. Br J Anaesth 2000; 85: 599-610
45. Oratz M, Rothschild MA, Schreiber SS. Effect of dextran infusions on protein synthesis by hepatic microsomes. Am J Physiol 1970; 218: 1108-1112
46. Ortega R, Gines P, Uriz J, et al. Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, nonrandomized study. Hepatology 2002; 36: 941-948
47. Parving HH, Ranek L, Lassen NA. Increased transcapillary escape rate of albumin in patients with cirrhosis of the liver. Scand J Clin Lab Invest 1977; 37: 643-648
48. Parving HH, Rossing N. Simultaneous determination of the transcapillary escape rate of albumin and IgG in normal and long-term juvenile diabetic subjects. Scand J Clin Lab Invest 1973; 32: 239-244
49. Peltekian KM, Wong F, Liu PP, Logan AG, Sherman M, Blendis LM. Cardiovascular, renal, and neurohumoral responses to single large-volume paracentesis in patients with cirrhosis and diuretic-resistant ascites. Am J Gastroenterol 1997; 92: 394-399
50. Planas R, Gines P, Arroyo V, et al. Dextran-70 versus albumin as plasma expanders in cirrhotic patients with tense ascites treated with total paracentesis. Results of a randomized study. Gastroenterology 1990; 99: 1736-1744
51. Quinlan GJ, Mumby S, Martin GS, Bernard GR, Gutteridge JM, Evans TW. Albumin influences total plasma antioxidant capacity favorably in patients with acute lung injury. Crit Care Med 2004; 32: 755-759
52. Rimola A, Garcia-Tsao G, Navasa M, et al. Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. J Hepatol 2000; 32: 142-153 (Pubitemid 30039459)
53. Romanelli RG, La Villa G, Barletta G, et al. Long-term albumin infusion improves survival in patients with cirrhosis and ascites: an unblinded randomized trial. World J Gastroenterol 2006; 12: 1403-1407
54. Rossing N. Intra-und extravascular distribution of albumin and immunoglobulin in man. Lymphology 1978; 11: 138-142
55. SAFE Study Investigators; Australian and New Zealand Intensive Care Society Clinical Trials Group; Australian Red Cross Blood Service; George Institute for International Health, Myburgh J, Cooper J, Finfer S, et al. Saline or albumin for fluid resuscitation in patients with traumatic brain injury. N Engl J Med 2007; 357: 874-884
56. Salerno F, Badalamenti S, Lorenzano E, Moser P, Incerti P. Randomized comparative study of hemaccel vs. albumin infusion after total paracentesis in cirrhotic patients with refractory ascites. Hepatology 1991; 13: 707-713
57. Schortgen F, Girou E, Deye N, Brochard L, for the CRYCO Study Group. The risk associated with hyperoncotic colloids in patients with shock. Intensive Care Med 2008; 34: 2157-2168
58. Sedrakyan A, Gondek K, Paltiel D, Elefteriades JA. Volume expansion with albumin decreases mortality after coronary artery bypass graft surgery. Chest 2003; 123: 1853-1857
59. So KW, Fok TF, Ng PC, Wong WW, Cheung K. Randomised controlled trial of colloid or crystalloid in hypotensive preterm infants. Arch Dis Child Fetal Neonatal Ed 1997; 76: F43-6
60. Solanki P, Chawla A, Garg R, Gupta R, Jain M, Sarin SK. Beneficial effects of terlipressin in hepatorenal syndrome: a prospective, randomized placebo-controlled clinical trial. J Gastroenterol Hepatol 2003; 18: 152-156
61. Sola-Vera J, Minana J, Ricart E, et al. Randomized trial comparing albumin and saline in the prevention of paracentesis-induced circulatory dysfunction in cirrhotic patients with ascites. Hepatology 2003; 37: 1147-1153
62. Sort P, Navasa M, Arroyo V, et al. Effects of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med 1999; 342: 403-409
63. Standl T, Lochbuehler H, Galli C, Reich A, Dietrich G, Hagemann H. HES 130/0.4 (Voluven) or human albumin in children younger than 2 yr undergoing non-cardiac surgery. A prospective, randomized, open label, multicentre trial. Eur J Anaesthesiol 2008; 25: 437-445
64. Stoddart PA, Rich P, Sury MRJ. A comparison of 4.5% human albumin solution and haemaccel in neonates undergoing major surgery. Paediatr Anaesth 1996; 6: 103-106
65. Sümpelmann R, Kretz FJ, Gäbler R, et al. Hydroxyethyl starch 130/0.42/6:1 for perioperative plasma volume replacement in children: preliminary results of a European Prospective Multicenter Observational Postauthorization Safety Study (PASS). Paediatr Anaesth 2008; 18: 929-933
66. Tanzi M, Gardner M, Megellas M, Lucio S, Restino M. Evaluation of the appropriate use of albumin in adult and pediatric patients. Am J Health Syst Pharm 2003; 60: 1330-1335
67. Technology Assessment: Albumin, Non-protein Colloid, and Crystalloid Solutions. Oak Book, IL, USA: University HealthSystem Consortium, 2000
68. van der Heijden M, Verheij J, van Nieuw Amerongen GP, Groeneveld AB. Crystalloid or colloid fluid loading and pulmonary permeability, edema, and injury in septic and nonseptic critically ill patients with hypovolemia. Crit Care Med 2009; 37: 1275-1281
69. Vincent JL, Dubois MJ, Navickis RJ, Wilkes MM. Hypoalbuminemia in acute illness: is there a rationale for intervention? A meta-analysis of cohort studies and controlled trials. Ann Surg 2003; 237: 319-334
70. Vincent JL, Navickis RJ, Wilkes MM. Morbidity in hospitalized patients receiving human albumin: a meta-analysis of randomized, controlled trials. Crit Care Med 2004; 32: 2029-2038
71. Vincent JL, Sakr Y, Reinhart K, 'Sepsis Occurrence in Acutely Ill Patients' Investigators. Is albumin administration in the acutely ill associated with increased mortality? Results of the SOAP study. Crit Care 2005; 9: R745-54
72. Vincent JL, Wilkes MM, Navickis RJ. Safety of human albuminserious adverse events reported worldwide in 1998-2000. Br J Anaesth 2003; 91: 625-630
73. Weber RJ, Kane SL, Oriolo VA, Saul M, Skledar SJ, Dasta JF. Impact of intensive care unit (ICU) drug use on hospital costs: a descriptive analysis, with recommendations for optimizing ICU pharmacotherapy. Crit Care Med 2003; 31: S17-24
74. Wilkes MM, Navickis RJ. Patient survival after human albumin administration-a meta-analysis of randomized controlled trials. Ann Intern Med 2001; 135: 149-164
75. Wilkes MM, Navickis RJ, Sibbald WJ. Albumin versus hydroxyethyl starch in cardiopulmonary bypass surgery: a meta-analysis of postoperative bleeding. Ann Thorac Surg 2001; 72: 527-533
76. Yuan XY, Zhang CH, He YL, et al. Is albumin administration beneficial in early stage of postoperative hypoalbuminemia following gastrointestinal surgery? A prospective randomized controlled trial. Am J Surg 2008; 196: 751-755